BPC-157 is a compounded peptide that is not FDA-approved for the indications described and is not marketed to treat, cure, prevent, or diagnose any disease
Dry Mouth (Xerostomia): Many medications, including some GLP-1 agonists, can reduce saliva production
The decision was a result of restricted access to healthcare facilities and supply chain bottlenecks during Covid | Getty Images Although it is not well defined, B12 deficiency has an estimated prevalence of around six percent in people under the age of 60 and closer to 20 percent in people aged over 60
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: a systematic review of the literature
Grand Rapids health and wellness specialists at Optimal Wellness Medical treat each patient as a unique individual providing customized care through innovative personalized medicine techniques
The fact that Retatrutide impacts GLP-1, GIP, and glucagon has earned it the nickname Triple G